Purple Biotech (Israel) Market Value
| PPBT Stock | ILA 6.80 2.00 41.67% |
| Symbol | Purple |
Purple Biotech 'What if' Analysis
In the world of financial modeling, what-if analysis is part of sensitivity analysis performed to test how changes in assumptions impact individual outputs in a model. When applied to Purple Biotech's stock what-if analysis refers to the analyzing how the change in your past investing horizon will affect the profitability against the current market value of Purple Biotech.
| 06/03/2024 |
| 11/30/2024 |
If you would invest 0.00 in Purple Biotech on June 3, 2024 and sell it all today you would earn a total of 0.00 from holding Purple Biotech or generate 0.0% return on investment in Purple Biotech over 180 days. Purple Biotech is related to or competes with Enlivex Therapeutics, Compugen, Purple Biotech, BioLine RX, Clal Biotechnology, and Evogene. Purple Biotech Ltd., a clinical-stage pharmaceutical company, focuses on the development and commercialization of variou... More
Purple Biotech Upside/Downside Indicators
Understanding different market momentum indicators often help investors to time their next move. Potential upside and downside technical ratios enable traders to measure Purple Biotech's stock current market value against overall market sentiment and can be a good tool during both bulling and bearish trends. Here we outline some of the essential indicators to assess Purple Biotech upside and downside potential and time the market with a certain degree of confidence.
| Information Ratio | (0.14) | |||
| Maximum Drawdown | 26.33 | |||
| Value At Risk | (10.20) | |||
| Potential Upside | 10.64 |
Purple Biotech Market Risk Indicators
Today, many novice investors tend to focus exclusively on investment returns with little concern for Purple Biotech's investment risk. Other traders do consider volatility but use just one or two very conventional indicators such as Purple Biotech's standard deviation. In reality, there are many statistical measures that can use Purple Biotech historical prices to predict the future Purple Biotech's volatility.| Risk Adjusted Performance | (0.09) | |||
| Jensen Alpha | (1.00) | |||
| Total Risk Alpha | (2.23) | |||
| Treynor Ratio | (3.55) |
Purple Biotech Backtested Returns
Purple Biotech maintains Sharpe Ratio (i.e., Efficiency) of -0.17, which implies the firm had a -0.17% return per unit of risk over the last 3 months. Purple Biotech exposes twenty-four different technical indicators, which can help you to evaluate volatility embedded in its price movement. Please check Purple Biotech's Risk Adjusted Performance of (0.09), variance of 57.84, and Coefficient Of Variation of (798.97) to confirm the risk estimate we provide. The company holds a Beta of 0.27, which implies not very significant fluctuations relative to the market. As returns on the market increase, Purple Biotech's returns are expected to increase less than the market. However, during the bear market, the loss of holding Purple Biotech is expected to be smaller as well. At this point, Purple Biotech has a negative expected return of -1.48%. Please make sure to check Purple Biotech's value at risk, skewness, accumulation distribution, as well as the relationship between the potential upside and kurtosis , to decide if Purple Biotech performance from the past will be repeated at some point in the near future.
Auto-correlation | 0.83 |
Very good predictability
Purple Biotech has very good predictability. Overlapping area represents the amount of predictability between Purple Biotech time series from 3rd of June 2024 to 1st of September 2024 and 1st of September 2024 to 30th of November 2024. The more autocorrelation exist between current time interval and its lagged values, the more accurately you can make projection about the future pattern of Purple Biotech price movement. The serial correlation of 0.83 indicates that around 83.0% of current Purple Biotech price fluctuation can be explain by its past prices.
| Correlation Coefficient | 0.83 | |
| Spearman Rank Test | 0.65 | |
| Residual Average | 0.0 | |
| Price Variance | 15.49 |
Purple Biotech lagged returns against current returns
Autocorrelation, which is Purple Biotech stock's lagged correlation, explains the relationship between observations of its time series of returns over different periods of time. The observations are said to be independent if autocorrelation is zero. Autocorrelation is calculated as a function of mean and variance and can have practical application in predicting Purple Biotech's stock expected returns. We can calculate the autocorrelation of Purple Biotech returns to help us make a trade decision. For example, suppose you find that Purple Biotech has exhibited high autocorrelation historically, and you observe that the stock is moving up for the past few days. In that case, you can expect the price movement to match the lagging time series.
Current and Lagged Values |
| Timeline |
Purple Biotech regressed lagged prices vs. current prices
Serial correlation can be approximated by using the Durbin-Watson (DW) test. The correlation can be either positive or negative. If Purple Biotech stock is displaying a positive serial correlation, investors will expect a positive pattern to continue. However, if Purple Biotech stock is observed to have a negative serial correlation, investors will generally project negative sentiment on having a locked-in long position in Purple Biotech stock over time.
Current vs Lagged Prices |
| Timeline |
Purple Biotech Lagged Returns
When evaluating Purple Biotech's market value, investors can use the concept of autocorrelation to see how much of an impact past prices of Purple Biotech stock have on its future price. Purple Biotech autocorrelation represents the degree of similarity between a given time horizon and a lagged version of the same horizon over the previous time interval. In other words, Purple Biotech autocorrelation shows the relationship between Purple Biotech stock current value and its past values and can show if there is a momentum factor associated with investing in Purple Biotech.
Regressed Prices |
| Timeline |
Also Currently Popular
Analyzing currently trending equities could be an opportunity to develop a better portfolio based on different market momentums that they can trigger. Utilizing the top trending stocks is also useful when creating a market-neutral strategy or pair trading technique involving a short or a long position in a currently trending equity.Additional Information and Resources on Investing in Purple Stock
When determining whether Purple Biotech is a good investment, qualitative aspects like company management, corporate governance, and ethical practices play a significant role. A comparison with peer companies also provides context and helps to understand if Purple Stock is undervalued or overvalued. This multi-faceted approach, blending both quantitative and qualitative analysis, forms a solid foundation for making an informed investment decision about Purple Biotech Stock. Highlighted below are key reports to facilitate an investment decision about Purple Biotech Stock:Check out Purple Biotech Correlation, Purple Biotech Volatility and Purple Biotech Alpha and Beta module to complement your research on Purple Biotech. For information on how to trade Purple Stock refer to our How to Trade Purple Stock guide.You can also try the Global Correlations module to find global opportunities by holding instruments from different markets.
Purple Biotech technical stock analysis exercises models and trading practices based on price and volume transformations, such as the moving averages, relative strength index, regressions, price and return correlations, business cycles, stock market cycles, or different charting patterns.